Deprenyl/l-dopa/carbidopa pharmaceutical composition

Details Deprenyl/l-dopa/carbidopa pharmaceutical composition Deprenyl/l-dopa/carbidopa pharmaceutical composition

A - Human Necessities

61

K

167/260

A61K 31/195 (2006.01) A61K 9/20 (2006.01) A61K 9/24 (2006.01) A61K 9/16 (2006.01) A61K 9/48 (2006.01)

Patent

CA 2037178

BP-6449-A TITLE SEPRENYL/L-DOPA/CARBIDOPA PHARMACEUTICAL COMPOSITION ABSTRACT OF THE DISCLOSURE Disclosed are pharmaceutical combination products useful for the treatment of Parkinson's disease. These products are based on a combination of active ingredients which are carbidopa, levodopa, and deprenyl in a pharmaceutical carrier, preferably a carrier wherein one or more of the active ingredients are in a sustained release oral dosage formation.

Affiliated with

Also associated with

Rating

Deprenyl/l-dopa/carbidopa pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Deprenyl/l-dopa/carbidopa pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deprenyl/l-dopa/carbidopa pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2077952